Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in recurrent cervical cancer
NCT00005837Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Feb 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of oxaliplatin in Cervical Cancer (CC), sponsored by GOG Foundation. Started Feb 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00005837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005837.